Fritz Schröder Opportunistic Prostate Screening May Not Save Lives! REFERENCE: AACR 2007, Los Angeles FRITZ SCHRÖDER, Erasmus University, Rotterdam Though elective screening appears to have reduced the number of patients who die from prostate...
PETER HARPER, Guy’s Hospital, London REFERENCE: “Management of Tumour and Treatment Related Symptoms” section, Perspectives in Lung Cancer, Seville Bisphosphonates may be more suited for improving the outlook among patients with...
George Canellos Robert Motzer Hormone Replacement Therapy: Better Survival With Colorectal Cancer REFERENCE: J Clin Oncol 24:5680-5686 GEORGE CANELLOS, Dana-Farber Cancer Institute, Boston Using postmenopausal estrogen replacement before the...
DAVID JABLONS, University of California, San Francisco REFERENCE: Keynote Lecture, Perspectives in Lung Cancer Conference, 2-3 March 2007, Seville, Spain Cell signalling using the Wnt pathway may hold the key to many, if not all, the genetic...
Lorie Hughes Rachel Ellsworth Rowan Chlebowski Victor Vogel Local Excision Alone for Selected Patients with Ductal Carcinoma In Situ? REFERENCE: Abstract: 29 LORIE HUGHES, The Hope Center, Cartersville GA The intergroup study E-5194 has found that...
Rachel Johnson Terry Mamounas William Gradishar Withhold Trastuzumab in Low-Risk Patients with HER-2 Positive Breast Cancer? REFERENCE: Abstract: 2090 RACHEL JOHNSON, Christie Hospital, Manchester Some patients with HER-2 positive early breast...
Francis Giles Ken Kaushansky Heather Leitch Nancy Berliner Corrado Tarella Vincent Rajkumar Robert Kyle Aurora Kinase BCR-ABL Inhibitor Beats T315-I Mutation in Patients with Chronic Myeloid Leukemia REFERENCE: Abstract: 163 FRANCIS GILES, M D...
Martin Müller Charles Linker Andreas Hochhaus Christian Buske Katarina Le Blanc Stephen Emerson Alessandro Vannucchi Kanti Rai Richard Schlenk BCR-ABL Mutations After Imatinib Failure: Impact on Response to Dasatinib REFERENCE: American Society of...
Clifford Hudis Mark Einstein Tony Greco James Berenson Edward Ambinder Breast Cancer: HER2 Still a Useful Target After Trastuzumab Resistance REFERENCE: Chemotherapy Foundation Symposium XXIV 8-11 November 2006 CLIFFORD HUDIS, Memorial Sloan...
Daniel Petrylak Oliver Sartor Mark Socinski Kanti Rai Edward Ambinder Chemo- and Immunotherapy Working Together in Hormone Refractory Prostate Cancer REFERENCE: Chemotherapy Foundation Symposium XXIV 8-11 November 2006 DANIEL PETRYLAK, Columbia...
David Cameron Martine Piccart Eric Van Cutsem Jim Cassidy Volker Heinemann Lapatinib Better for Patients with HER2+ Refractory Breast Cancer Pre-treated with Chemotherapy and Trastuzumab REFERENCE: ESMO 2006, Abstract: 141O David Cameron, Western...
Gordon McVie Martine Piccart Bella Kaufman Jean-Yves Douillard ESMO Congress Reviewed GORDON MCVIE, European Institute of Oncology, Milan In Istanbul, Gordon McVie gave his opinion about the achievements of the 2006 European Society for Medical...